The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shmukler A.B.

Serbsky National Medical Research Center of Psychiatry and Narcology

Kostyuk G.P.

Alekseev Psychiatric Clinical Hospital No. 1

Latanov A.V.

Lomonosov Moscow State University

Sidorova M.Yu.

Lomonosov Moscow State University

Anisimov V.N.

Lomonosov Moscow State University

Zakharova N.V.

Alekseev Moscow Psychiatric Hospital No. 1

Karyakina M.V.

Serbsky National Medical Research Center of Psychiatry and Narcology

Reznik A.M.

Moscow State University of Food Production

Sokolov A.V.

Alekseev Psychiatric Clinical Hospital No. 1

Spektor V.A.

Serbsky National Medical Research Center of Psychiatry and Narcology

Sukhachevskii I.S.

Serbsky National Medical Research Center of Psychiatry and Narcology

Churikova M.A.

Lomonosov Moscow State University

Network analysis of cognitive, oculomotor and speech parameters in schizophrenia

Authors:

Shmukler A.B., Kostyuk G.P., Latanov A.V., Sidorova M.Yu., Anisimov V.N., Zakharova N.V., Karyakina M.V., Reznik A.M., Sokolov A.V., Spektor V.A., Sukhachevskii I.S., Churikova M.A.

More about the authors

Read: 2519 times


To cite this article:

Shmukler AB, Kostyuk GP, Latanov AV, et al. . Network analysis of cognitive, oculomotor and speech parameters in schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6‑2):54‑60. (In Russ.)
https://doi.org/10.17116/jnevro202012006254

Recommended articles:
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
A role of transcription factors in pathogenic processes asso­ciated with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):49-54
Meta­bolic syndrome and anti­psychotic therapy of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):165-170
PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):28-34
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Clinical and psychopathological features of treatment-resistant schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50

References:

  1. Reznik AM, Kostyuk GP, Hannanova AN. Vulnerability for schizophrenia on the basis of molecular genetics investigations. Socialnaya i Klinicheskaya Psihiatriya. 2016;26(3):101-108. (In Russ.).
  2. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry. 2010;167:748-751.  https://doi.org/10.1176/appi.ajp.2010.09091379
  3. Cuthbert BN. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry.2014;13(1):28-35.  https://doi.org/10.1002/wps.20087
  4. Harrison LA, Kats A, Williams ME, Aziz-Zadeh L. The Importance of Sensory Processing in Mental Health: A Proposed Addition to the Research Domain Criteria (RDoC) and Suggestions for RDoC 2.0. Front Psychol. 2019;5(10):103.  https://doi.org/10.3389/fpsyg.2019.00103
  5. Borsboom DA. Network theory of mental disorders. World Psychiatry. 2017;16(1):5-13.  https://doi.org/10.1002/wps.20375
  6. Hofmann SG, Curtiss J. A complex network approach to clinical science. Eur J Clin Invest. 2018;48(8):e12986. https://doi.org/10.1111/eci.12986
  7. Fried EI, van Borkulo CD, Cramer AO, Boschloo L, Schoevers RA, Borsboom D. Mental disorders as networks of problems: a review of recent insights. Soc Psychiatry PsychiatrEpidemiol. 2017;52(1):1-10.  https://doi.org/10.1007/s00127-016-1319-z
  8. Gurovish IYa, Shmukler AB. Pervyi psihoticheskii epizod (problem i psihiatricheskaya pomosch). Monografiya. M.: Medpraktika-M; 2010. (In Russ.).
  9. Weisbrod M, Kiefer M, Marzinzik F, Spitzer M. Executive control is disturbed in schizophrenia: evidence from event-related potentials in a Go/NoGo task. Biol Psychiatry. 2000;7(1):51-60. 
  10. Gooding DC, Basso MA. The tell-tale tasks: a review of saccadic research in psychiatric patient populations. Brain Cogn. 2008;68(3):371-390.  https://doi.org/10.1016/j.bandc.2008.08.024
  11. Cutsuridis V, Kumari V, Ettinger U. Antisaccade performance in schizophrenia: a neural model of decision making in the superior colliculus. Front Neurosci. 2014;11(8):13.  https://doi.org/10.3389/fnins.2014.00013
  12. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 2010;47(5):846-856.  https://doi.org/10.1111/j.1469-8986.2010.01004.x
  13. Karyakina MV, Sidorova MYu, Shmukler AB. Speechdisordersinschizophreniapatients. Socialnaya i Klinicheskaya Psihiatriya. 2017;27(4):93-100. (In Russ.).
  14. Mezhdunarodnaya klassifikaciya boleznei (10-iperesmotr). SPb.: ADIS; 1994. (In Russ.).
  15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Washington, DC: American Psychiatric Association; 2013.
  16. Bedi G, Carrillo F, Cecchi GA, Slezak DF, Sigman M, Mota NB, Ribeiro S, Javitt DC, Copelli M, Corcoran CM. Automated analysis of free speech predicts psychosis onset in high-risk youths. NPJ Schizophr. 2015;1:15030. https://doi.org/10.1038/npjschz.2015.30
  17. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13:261-276.  https://doi.org/10.1093/schbul/13.2.261
  18. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3(4):247-251. 
  19. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry.1978;133:429-435. 
  20. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand. 1970;212(suppl):11-19. 
  21. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989;14:672-676. 
  22. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68:283-297. 
  23. Sarkisyan GR, Gurovich IYa, Keefe RS. Normative data for the Russian population and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) scale. Socialnaya i Klinicheskaya Psihiatriya. 2010;20(3):13-19. (In Russ.).
  24. Anisimov VN, Krasnoperov AV, Serzhenko FL, Tereschenko LV. Razrabotka tehnologii aitrekinga ot registracii videodonalojeniya trekov na izobrajenie. Aitreking v psihologicheskoi nauke i prektike. M.: Moskovskii institutep sihoanaliza; 2016. (In Russ.).
  25. Mosolov SN. Shkaly psihometricheskoi ocenki shizofrenii i koncepciya pozitivnyh i negativnyh rasstroistv. M.: Noviicvet; 2001. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.